These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 15611972)

  • 1. The "microscopic" revolution in breast carcinoma.
    Cristofanilli M
    Cancer; 2005 Mar; 103(5):877-80. PubMed ID: 15611972
    [No Abstract]   [Full Text] [Related]  

  • 2. [Diagnosis and clinical significance of disseminated tumor cells in bone marrow].
    Braun S; Pantel K
    Dtsch Med Wochenschr; 2000 Oct; 125(41):1237-9. PubMed ID: 11076263
    [No Abstract]   [Full Text] [Related]  

  • 3. Prognostic significance of tumor cells in the bone marrow.
    Mendoza CB; Moore GE; Crosswhite LH; Sandberg AA; Watne AL
    Surg Gynecol Obstet; 1969 Sep; 129(3):483-8. PubMed ID: 5820928
    [No Abstract]   [Full Text] [Related]  

  • 4. The persistence of isolated tumor cells in bone marrow from patients with breast carcinoma predicts an increased risk for recurrence.
    Janni W; Rack B; Schindlbeck C; Strobl B; Rjosk D; Braun S; Sommer H; Pantel K; Gerber B; Friese K
    Cancer; 2005 Mar; 103(5):884-91. PubMed ID: 15666325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone marrow metastases in breast cancer.
    Pikarsky E; Peretz T
    N Engl J Med; 2000 Aug; 343(8):577-8. PubMed ID: 10979783
    [No Abstract]   [Full Text] [Related]  

  • 6. Bone marrow metastases in breast cancer.
    Diaz-Cano SJ
    N Engl J Med; 2000 Aug; 343(8):577; author reply 578. PubMed ID: 10979781
    [No Abstract]   [Full Text] [Related]  

  • 7. Significance of micrometastasis in bone marrow and blood of operable breast cancer patients: research tool or clinical application?
    Lang JE; Hall CS; Singh B; Lucci A
    Expert Rev Anticancer Ther; 2007 Oct; 7(10):1463-72. PubMed ID: 17944570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone marrow metastases in breast cancer.
    Funke I; Schraut W
    N Engl J Med; 2000 Aug; 343(8):577; author reply 578. PubMed ID: 10979782
    [No Abstract]   [Full Text] [Related]  

  • 9. Disseminated tumor cells of breast cancer patients: a strong prognostic factor for distant and local relapse.
    Bidard FC; Vincent-Salomon A; Gomme S; Nos C; de Rycke Y; Thiery JP; Sigal-Zafrani B; Mignot L; Sastre-Garau X; Pierga JY;
    Clin Cancer Res; 2008 Jun; 14(11):3306-11. PubMed ID: 18519757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insurgent micrometastases: sleeper cells and harboring the enemy.
    Wieder R
    J Surg Oncol; 2005 Mar; 89(4):207-10. PubMed ID: 15726617
    [No Abstract]   [Full Text] [Related]  

  • 11. Metastatic tumor in bone-marrow biopsy.
    Lake-Lewin D; Tang CK; Gray GF
    N Y State J Med; 1975 Jun; 75(7):1008-11. PubMed ID: 1056526
    [No Abstract]   [Full Text] [Related]  

  • 12. Detection, clinical relevance and specific biological properties of disseminating tumour cells.
    Pantel K; Brakenhoff RH; Brandt B
    Nat Rev Cancer; 2008 May; 8(5):329-40. PubMed ID: 18404148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Researchers exploring implications of minimal residual cancer.
    McBride G
    J Natl Cancer Inst; 2005 Nov; 97(22):1642-3. PubMed ID: 16288116
    [No Abstract]   [Full Text] [Related]  

  • 14. Detection of cytokeratin-positive cells in the bone marrow of breast cancer patients undergoing adjuvant therapy.
    Becker S; Becker-Pergola G; Wallwiener D; Solomayer EF; Fehm T
    Breast Cancer Res Treat; 2006 May; 97(1):91-6. PubMed ID: 16319975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary systemic therapy does not eradicate disseminated tumor cells in breast cancer patients.
    Becker S; Solomayer E; Becker-Pergola G; Wallwiener D; Fehm T
    Breast Cancer Res Treat; 2007 Dec; 106(2):239-43. PubMed ID: 17260094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disseminated tumor cells in bone marrow and circulating tumor cells in blood of breast cancer patients: current state of detection and characterization.
    Riethdorf S; Pantel K
    Pathobiology; 2008; 75(2):140-8. PubMed ID: 18544969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of minimal residual disease in blood and bone marrow in early stage breast cancer.
    Kuo JF; Lin WL; Han CP
    Cancer; 2011 Jun; 117(11):2578; author reply 2579. PubMed ID: 21437894
    [No Abstract]   [Full Text] [Related]  

  • 18. Metastatic breast cancer.
    Stevanovic A; Lee P; Wilcken N
    Aust Fam Physician; 2006 May; 35(5):309-12. PubMed ID: 16680209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crosstalk between cancer cells and bone microenvironment in bone metastasis.
    Yoneda T; Hiraga T
    Biochem Biophys Res Commun; 2005 Mar; 328(3):679-87. PubMed ID: 15694401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Approaches to breast-cancer staging.
    Smith BL
    N Engl J Med; 2000 Feb; 342(8):580-1. PubMed ID: 10684918
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.